ipriflavone has been researched along with Leiomyoma in 3 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Leiomyoma: A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ipriflavone efficaciously alleviated the adverse effects of estrogen deficiency such as bone loss and increase in LDL-C level, and the ability of leuprolide therapy to reduce myoma volume was not decreased by ipriflavone administration." | 2.70 | Efficacy of ipriflavone in preventing adverse effects of leuprolide. ( Aso, T; Chiguchi, M; Ishibashi, T; Somekawa, Y; Wakana, K, 2001) |
| "Uterine fibroids (also known as leiomyomas) are the most common benign pelvic tumours among women." | 2.52 | Add-back therapy with GnRH analogues for uterine fibroids. ( Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moroni, RM | 1 |
| Martins, WP | 1 |
| Ferriani, RA | 1 |
| Vieira, CS | 1 |
| Nastri, CO | 1 |
| Candido Dos Reis, FJ | 1 |
| Brito, LG | 1 |
| Gambacciani, M | 1 |
| Cappagli, B | 1 |
| Piaggesi, L | 1 |
| Ciaponi, M | 1 |
| Genazzani, AR | 1 |
| Somekawa, Y | 1 |
| Chiguchi, M | 1 |
| Ishibashi, T | 1 |
| Wakana, K | 1 |
| Aso, T | 1 |
1 review available for ipriflavone and Leiomyoma
| Article | Year |
|---|---|
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combi | 2015 |
2 trials available for ipriflavone and Leiomyoma
| Article | Year |
|---|---|
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.
Topics: Absorptiometry, Photon; Analysis of Variance; Antineoplastic Agents, Hormonal; Bone Density; Bone Re | 1997 |
Efficacy of ipriflavone in preventing adverse effects of leuprolide.
Topics: Adult; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Antagonists; Female; | 2001 |